Alessi P - Search Results

1

Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, Halin C, Castellani P, Zardi L, Hofer CK, Montani M, Neri D, Lüscher TF. Matter CM, et al. Among authors: alessi p. Circ Res. 2004 Dec 10;95(12):1225-33. doi: 10.1161/01.RES.0000150373.15149.ff. Epub 2004 Nov 11. Circ Res. 2004. PMID: 15539632

2

Molecular targeting of angiogenesis.

Alessi P, Ebbinghaus C, Neri D. Alessi P, et al. Biochim Biophys Acta. 2004 Mar 4;1654(1):39-49. doi: 10.1016/j.bbcan.2003.08.001. Biochim Biophys Acta. 2004. PMID: 14984766 Review.

3

Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy.

Heinis C, Alessi P, Neri D. Heinis C, et al. Among authors: alessi p. Biochemistry. 2004 May 25;43(20):6293-303. doi: 10.1021/bi0361160. Biochemistry. 2004. PMID: 15147213

4

Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.

Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, Treyer V, Weber B, Neri D, Buck A. Wyss MT, et al. Among authors: alessi p. J Nucl Med. 2007 Apr;48(4):608-14. doi: 10.2967/jnumed.106.036251. J Nucl Med. 2007. PMID: 17401099 Free article.

5

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

Fabbrini M, Trachsel E, Soldani P, Bindi S, Alessi P, Bracci L, Kosmehl H, Zardi L, Neri D, Neri P. Fabbrini M, et al. Among authors: alessi p. Int J Cancer. 2006 Apr 1;118(7):1805-13. doi: 10.1002/ijc.21412. Int J Cancer. 2006. PMID: 16217760

6

Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.

Ronca R, Sozzani S, Presta M, Alessi P. Ronca R, et al. Among authors: alessi p. Immunobiology. 2009;214(9-10):800-10. doi: 10.1016/j.imbio.2009.06.005. Epub 2009 Jul 21. Immunobiology. 2009. PMID: 19625102 Review.

7

Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.

Ronca R, Benzoni P, Leali D, Urbinati C, Belleri M, Corsini M, Alessi P, Coltrini D, Calza S, Presta M, Dell'Era P. Ronca R, et al. Among authors: alessi p. Mol Cancer Ther. 2010 Dec;9(12):3244-53. doi: 10.1158/1535-7163.MCT-10-0417. Epub 2010 Oct 12. Mol Cancer Ther. 2010. PMID: 20940322 Free article.

8

Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses.

Caserta S, Alessi P, Guarnerio J, Basso V, Mondino A. Caserta S, et al. Among authors: alessi p. Cancer Res. 2008 Apr 15;68(8):3010-8. doi: 10.1158/0008-5472.CAN-07-5796. Cancer Res. 2008. PMID: 18413771

9

Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.

Ronca R, Alessi P, Coltrini D, Di Salle E, Giacomini A, Leali D, Corsini M, Belleri M, Tobia C, Garlanda C, Bonomi E, Tardanico R, Vermi W, Presta M. Ronca R, et al. Among authors: alessi p. J Pathol. 2013 Jun;230(2):228-38. doi: 10.1002/path.4181. J Pathol. 2013. PMID: 23424081

10

Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.

Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M. Ronca R, et al. Among authors: alessi p. Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15. Mol Cancer Ther. 2013. PMID: 24130051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters